KR840000964B1 - 15-설폰아미도프로스타글란딘 유도체의 제조방법 - Google Patents

15-설폰아미도프로스타글란딘 유도체의 제조방법 Download PDF

Info

Publication number
KR840000964B1
KR840000964B1 KR1019800003623A KR800003623A KR840000964B1 KR 840000964 B1 KR840000964 B1 KR 840000964B1 KR 1019800003623 A KR1019800003623 A KR 1019800003623A KR 800003623 A KR800003623 A KR 800003623A KR 840000964 B1 KR840000964 B1 KR 840000964B1
Authority
KR
South Korea
Prior art keywords
solution
acid
reaction
derivative
mmol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
KR1019800003623A
Other languages
English (en)
Korean (ko)
Other versions
KR830003415A (ko
Inventor
켄 샤프 토마스
프레드릭 에글러 제임스
Original Assignee
화이자 인코포레이티드
윌리암 지 · 맥크리이리
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 화이자 인코포레이티드, 윌리암 지 · 맥크리이리 filed Critical 화이자 인코포레이티드
Publication of KR830003415A publication Critical patent/KR830003415A/ko
Application granted granted Critical
Publication of KR840000964B1 publication Critical patent/KR840000964B1/ko
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0041—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing nitrogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/04—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
KR1019800003623A 1979-09-17 1980-09-16 15-설폰아미도프로스타글란딘 유도체의 제조방법 Expired KR840000964B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US076.520 1979-09-17
US06/076,520 US4232173A (en) 1979-09-17 1979-09-17 15-Sulfonamidoprostaglandin derivatives
US076520 1979-09-17

Publications (2)

Publication Number Publication Date
KR830003415A KR830003415A (ko) 1983-06-20
KR840000964B1 true KR840000964B1 (ko) 1984-07-02

Family

ID=22132532

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019800003623A Expired KR840000964B1 (ko) 1979-09-17 1980-09-16 15-설폰아미도프로스타글란딘 유도체의 제조방법

Country Status (18)

Country Link
US (1) US4232173A (enExample)
EP (1) EP0025687B1 (enExample)
JP (1) JPS5951938B2 (enExample)
KR (1) KR840000964B1 (enExample)
AR (1) AR225776A1 (enExample)
AT (1) ATE1858T1 (enExample)
AU (1) AU518068B2 (enExample)
CA (1) CA1153368A (enExample)
DE (1) DE3061160D1 (enExample)
DK (1) DK392580A (enExample)
ES (1) ES8106489A1 (enExample)
FI (1) FI68615C (enExample)
GR (1) GR70288B (enExample)
IE (1) IE50266B1 (enExample)
IL (1) IL61038A (enExample)
PH (1) PH15098A (enExample)
PT (1) PT71807B (enExample)
YU (1) YU236180A (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61126069A (ja) * 1984-11-21 1986-06-13 Res Dev Corp Of Japan プロスタグランジン誘導体
JPS63207015A (ja) * 1987-02-23 1988-08-26 株式会社日立製作所 遮断器装置
US5387608A (en) * 1993-08-17 1995-02-07 Allergan, Inc. Cyclopentane(ene) heptanoic or cyclopentane(ene) heptenoic acid, 2-hydrocarbyl sulfonamidomethyl and derivatives thereof as therapeutic agents
US5607415A (en) * 1994-08-18 1997-03-04 Kimberly-Clark Corporation Flexible absorbent article

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3835179A (en) * 1972-07-24 1974-09-10 American Cyanamid Co Novel 15-substituted prostanoic acids and esters
US4033996A (en) * 1973-04-25 1977-07-05 Merck & Co., Inc. 8-Aza-9-oxo(and dioxo)-thia-11,12-secoprostaglandins
GB1507211A (en) * 1975-02-14 1978-04-12 Ono Pharmaceutical Co Prostaglandin analogues

Also Published As

Publication number Publication date
EP0025687A1 (en) 1981-03-25
CA1153368A (en) 1983-09-06
AU518068B2 (en) 1981-09-10
IL61038A (en) 1983-12-30
EP0025687B1 (en) 1982-11-24
ES495101A0 (es) 1981-08-16
PT71807B (en) 1981-07-02
IE801927L (en) 1981-03-17
JPS5951938B2 (ja) 1984-12-17
IL61038A0 (en) 1980-11-30
PT71807A (en) 1980-10-01
FI68615B (fi) 1985-06-28
ATE1858T1 (de) 1982-12-15
JPS5651448A (en) 1981-05-09
FI802904A7 (fi) 1981-03-18
YU236180A (en) 1983-01-21
DE3061160D1 (en) 1982-12-30
DK392580A (da) 1981-03-18
AR225776A1 (es) 1982-04-30
KR830003415A (ko) 1983-06-20
IE50266B1 (en) 1986-03-19
PH15098A (en) 1982-08-10
ES8106489A1 (es) 1981-08-16
GR70288B (enExample) 1982-09-03
AU6243680A (en) 1981-03-26
US4232173A (en) 1980-11-04
FI68615C (fi) 1985-10-10

Similar Documents

Publication Publication Date Title
CA1324129C (en) Prostaglandins of the f series
EP0299914B1 (de) 9-Halogen-(Z)-prostaglandinderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE2365035C2 (de) trans-Δ↑2↑-Prostaglandine, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Mittel
CS236484B2 (en) Method of 9-fluorprostaglandine derivatives production
DE2355540C2 (de) 16-Phenoxy-ω-tetranorprostaglandinderivate
US4022794A (en) Novel analogs of prostaglandins with 4-oxo-thiazolidinyl nucleus and method of preparation thereof
DE2626888C2 (de) Optisch aktive 11-Desoxy-16-aryloxy-ω-tetranorprostaglandine, Verfahren zu ihrer Herstellung und pharmazeutische Zubereitungen, die diese Verbindungen enthalten
KR840000964B1 (ko) 15-설폰아미도프로스타글란딘 유도체의 제조방법
NO763451L (enExample)
FI70009C (fi) Foerfarande foer framstaellning av nya 1,5-disubstituerad-2-pyrrolidonfoereningar vilka har prostaglandinliknande biologiska egenskaper
CH634831A5 (en) Process for the preparation of optically active or racemic prostaglandins.
US4304783A (en) Thienyl, thienyloxy or furyl substituted prostaglandin derivatives in the 6-keto-PGE1 series
CH642063A5 (de) Verfahren zur herstellung von prostaglandin-analoga, bei welchen die carbonylgruppe am c-9 durch eine methylengruppe ersetzt ist.
US4163016A (en) 16-Substituted prostaglandins
CA1049509A (en) Cyclopentane derivatives and process for preparing them
US4404372A (en) 15-Substituted-ω-pentanorprostaglandin derivatives
US4204074A (en) 16-Substituted prostaglandins
CH630898A5 (de) Verfahren zur herstellung neuer prostaglandin-analoga mit dreifachbindung zwischen c-13 und c-14.
US4292444A (en) Sulfonyl prostaglandin carboxamide derivatives
KR950005775B1 (ko) 4-하이드록시-4-(치환된 알케닐)사이클로헥산 카복실산
US4342868A (en) 2-Descarboxy-2-(tetrazol-5-yl)-16,16-dimethyl-17-(2-furyl)-ω-trisnorprostaglandin E2
US4418205A (en) 16-Amino-18,19,20-trinor-prostaglandin derivatives, and acid addition salts
US4530933A (en) 8-Aza-13-thiaprostanoids and a method of use thereof as anti-ulcer agents
US4244887A (en) Substituted ω-pentanorprostaglandins
NO790122L (no) Fremgangsmaate for fremstilling av prostaglandinkarboksamider

Legal Events

Date Code Title Description
PA0109 Patent application

St.27 status event code: A-0-1-A10-A12-nap-PA0109

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PG1605 Publication of application before grant of patent

St.27 status event code: A-2-2-Q10-Q13-nap-PG1605

PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U11-oth-PR1002

Fee payment year number: 1

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 5

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 6

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 7

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 8

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 9

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 10

PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 19940703

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 19940703

PN2301 Change of applicant

St.27 status event code: A-5-5-R10-R13-asn-PN2301

St.27 status event code: A-5-5-R10-R11-asn-PN2301

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000